Insider Transactions in Q1 2022 at Cin Cor Pharma, Inc. (CINC)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 11
2022
|
Mary Theresa Coelho EVP CFO & Chief BD Officer |
BUY
Open market or private purchase
|
Indirect |
100
+50.0%
|
$1,600
$16.0 P/Share
|
|
Jan 11
2022
|
Marc De Garidel Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
12,500
+50.0%
|
$200,000
$16.0 P/Share
|
|
Jan 11
2022
|
Mason Freeman Chief Medical Officer |
BUY
Open market or private purchase
|
Indirect |
100
+50.0%
|
$1,600
$16.0 P/Share
|
|
Jan 11
2022
|
Mason Freeman Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
2,500
+50.0%
|
$40,000
$16.0 P/Share
|
|
Jan 11
2022
|
Catherine Pearce Chief Operating Officer |
BUY
Open market or private purchase
|
Indirect |
1,500
+50.0%
|
$24,000
$16.0 P/Share
|
|
Jan 11
2022
|
Catherine Pearce Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
750
+0.57%
|
$12,000
$16.0 P/Share
|
|
Jan 11
2022
|
James Healy Director |
BUY
Open market or private purchase
|
Indirect |
325,000
+5.51%
|
$5,200,000
$16.0 P/Share
|
|
Jan 11
2022
|
James Healy Director |
BUY
Conversion of derivative security
|
Indirect |
5,248,949
+50.0%
|
-
|
|
Jan 11
2022
|
Sofinnova Partners Sas > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
220,000
+5.11%
|
$3,520,000
$16.0 P/Share
|
|
Jan 11
2022
|
Sofinnova Partners Sas > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
3,867,646
+50.0%
|
-
|
|
Jan 11
2022
|
Sofinnova Venture Partners X, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
325,000
+5.51%
|
$5,200,000
$16.0 P/Share
|
|
Jan 11
2022
|
Sofinnova Venture Partners X, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
5,248,949
+50.0%
|
-
|
|
Jan 11
2022
|
Cin Rx Pharma, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
1,222,530
+25.19%
|
-
|
|
Jan 11
2022
|
5 Am Partners Vi, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
470,000
+21.29%
|
$7,520,000
$16.0 P/Share
|
|
Jan 11
2022
|
5 Am Partners Vi, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
3,867,646
+50.0%
|
-
|
|
Jan 11
2022
|
General Atlantic Genpar (Bermuda), L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,700,000
+29.18%
|
$27,200,000
$16.0 P/Share
|
|
Jan 11
2022
|
General Atlantic Genpar (Bermuda), L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
2,426,470
+50.0%
|
-
|
|
Jan 11
2022
|
General Atlantic LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,700,000
+29.18%
|
$27,200,000
$16.0 P/Share
|
|
Jan 11
2022
|
General Atlantic LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
2,426,470
+50.0%
|
-
|